Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly A Saffran

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Nature Communications|October 21, 2020
Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replicationWayne Vuong, Muhammad Bashir Khan, Conrad Fischer, et al.
Nature Communications|August 29, 2020
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replicationWayne Vuong, Muhammad Bashir Khan, Conrad Fischer, et al.
Vaccine|September 5, 2021
SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1John Lok Man Law, Michael Logan, Michael A Joyce, et al.
European Journal of Medicinal Chemistry|June 12, 2021
Improved SARS-CoV-2 M<sup>pro</sup> inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studiesWayne Vuong, Conrad Fischer, Muhammad Bashir Khan, et al.
RSC Medicinal Chemistry|November 15, 2021
Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitorsBing Bai, Elena Arutyunova, Muhammad Bashir Khan, et al.
NPJ Vaccines|April 27, 2022
Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamstersGeorge Giorgi Babuadze, Hugues Fausther-Bovendo, Marc-Antoine deLaVega, et al.
Clinical & Translational Immunology|March 18, 2021
Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2Manisha Pandey, Victoria Ozberk, Sharareh Eskandari, et al.
Journal of Medicinal Chemistry|July 9, 2021
Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and <i>in Vitro</i> Biological StabilityBing Bai, Alexandr Belovodskiy, Mostofa Hena, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Nature Communications|October 21, 2020
Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replicationWayne Vuong, Muhammad Bashir Khan, Conrad Fischer, et al.
Nature Communications|August 29, 2020
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replicationWayne Vuong, Muhammad Bashir Khan, Conrad Fischer, et al.
Vaccine|September 5, 2021
SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1John Lok Man Law, Michael Logan, Michael A Joyce, et al.
European Journal of Medicinal Chemistry|June 12, 2021
Improved SARS-CoV-2 M<sup>pro</sup> inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studiesWayne Vuong, Conrad Fischer, Muhammad Bashir Khan, et al.
RSC Medicinal Chemistry|November 15, 2021
Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitorsBing Bai, Elena Arutyunova, Muhammad Bashir Khan, et al.
NPJ Vaccines|April 27, 2022
Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamstersGeorge Giorgi Babuadze, Hugues Fausther-Bovendo, Marc-Antoine deLaVega, et al.
Clinical & Translational Immunology|March 18, 2021
Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2Manisha Pandey, Victoria Ozberk, Sharareh Eskandari, et al.
Journal of Medicinal Chemistry|July 9, 2021
Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and <i>in Vitro</i> Biological StabilityBing Bai, Alexandr Belovodskiy, Mostofa Hena, et al.
Pageof 3